322 related articles for article (PubMed ID: 35885067)
1. Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma.
Matsui JK; Perlow HK; Ritter AR; Upadhyay R; Raval RR; Thomas EM; Beyer SJ; Pillainayagam C; Goranovich J; Ong S; Giglio P; Palmer JD
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885067
[TBL] [Abstract][Full Text] [Related]
2. Radioresistance in Glioblastoma and the Development of Radiosensitizers.
Ali MY; Oliva CR; Noman ASM; Allen BG; Goswami PC; Zakharia Y; Monga V; Spitz DR; Buatti JM; Griguer CE
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899427
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
Fabian D; Guillermo Prieto Eibl MDP; Alnahhas I; Sebastian N; Giglio P; Puduvalli V; Gonzalez J; Palmer JD
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717372
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
Mathen P; Rowe L; Mackey M; Smart D; Tofilon P; Camphausen K
Neurooncol Pract; 2020 Jun; 7(3):268-276. PubMed ID: 32537176
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Treatment Modalities besides Surgery.
Zhang H; Wang R; Yu Y; Liu J; Luo T; Fan F
J Cancer; 2019; 10(20):4793-4806. PubMed ID: 31598150
[TBL] [Abstract][Full Text] [Related]
9. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
10. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
[TBL] [Abstract][Full Text] [Related]
11. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
12. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
Ene CI; Cimino PJ; Fine HA; Holland EC
Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
[TBL] [Abstract][Full Text] [Related]
13. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
14. Tumor treating fields with radiation for glioblastoma: a narrative review.
Miller R; Niazi M; Russial O; Poiset S; Shi W
Chin Clin Oncol; 2022 Oct; 11(5):40. PubMed ID: 36336899
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
16. An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
Neagu MR; Reardon DA
Curr Treat Options Oncol; 2015 Nov; 16(11):54. PubMed ID: 26454859
[TBL] [Abstract][Full Text] [Related]
17. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
[TBL] [Abstract][Full Text] [Related]
18. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
Corso CD; Bindra RS
Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
[TBL] [Abstract][Full Text] [Related]
19. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
[TBL] [Abstract][Full Text] [Related]
20. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches.
McMahon DJ; Gleeson JP; O'Reilly S; Bambury RM
Med Oncol; 2022 Jun; 39(9):129. PubMed ID: 35716200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
